T1期结直肠癌内镜切除的围手术期不良事件
该多中心回顾性队列研究纳入2000至2014年荷兰15家医院1069例接受原发内镜切除的T1期结直肠癌患者,内镜相关不良事件发生率为5.5%,其中轻度37.3%、中度59.3%、重度3.4%,无致死性事件。年龄>70岁和肿瘤大小>20 mm是不良事件的独立预测因素。
要点
- T1期结直肠癌内镜切除的不良事件率为5.5%,与腺瘤切除报告的发生率相当。
- 年龄>70岁和肿瘤大小>20 mm是不良事件的独立预测因素。
- 术后出血最常见(3.7%),穿孔1.2%,息肉切除后电凝综合征0.6%。
核心结论
- T1期结直肠癌内镜治疗的围手术期不良事件风险并未增加。
- 年龄>70岁和肿瘤大小>20 mm是不良事件的独立预测因素。
研究设计与样本
- 多中心回顾性队列研究,回顾2000至2014年荷兰15家医院诊断为T1期结直肠癌的患者医疗记录。
- 纳入接受原发内镜切除的患者,主要结局为内镜相关不良事件,次要结局为风险因素识别,采用多因素logistic回归分析。
主要发现
- 1069例患者中59例(5.5%)发生内镜不良事件,其中轻度37.3%、中度59.3%、重度3.4%。
- 不良事件包括术后出血40例(3.7%)、穿孔13例(1.2%)、息肉切除后电凝综合征6例(0.6%)。
- 未观察到致死性不良事件。
- 年龄>70岁的比值比为2.11(95%CI 1.12-3.96),肿瘤大小>20 mm的比值比为2.22(95%CI 1.05-4.69)。
临床怎么用
- 对于T1期结直肠癌患者,内镜切除的围手术期不良事件风险与腺瘤切除相当,可支持内镜治疗的应用。
- 对年龄>70岁或肿瘤>20 mm的患者,应加强围手术期不良事件的监测与防范。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: In contrast to the adverse event (AE) risk of endoscopic resection (ER) of adenomas, the intra- and postprocedural AE risks of ER of T1 colorectal cancer (CRC) are scarcely reported in the literature. It is unclear whether ER of early CRCs, which grow into the submucosal layer and sometimes show incomplete lifting, is associated with an increased AE risk. We aimed to identify the AE rate after ER of T1 CRCs and to identify the risk factors associated with these AEs. METHODS: Medical records of patients with T1 CRCs diagnosed between 2000 and 2014 in 15 hospitals in the Netherlands were reviewed. Patients who underwent primary ER were selected. The primary outcome was the occurrence of endoscopy-related AEs. The secondary outcome was the identification of risk factors. Multivariate logistic regression was performed. RESULTS: Endoscopic AEs occurred in 59 of 1069 (5.5%) patients, among which 37.3% were classified as mild, 59.3% as moderate, and 3.4% as severe. AEs were postprocedural bleeding (n = 40, 3.7%), perforation (n = 13, 1.2%), and postpolypectomy electrocoagulation syndrome (n = 6, 0.6%). No fatal AEs were observed. Independent predictors for AEs were age >70 years (odds ratio, 2.11; 95% confidence interval, 1.12-3.96) and tumor size >20 mm (odds ratio, 2.22; 95% confidence interval, 1.05-4.69). CONCLUSIONS: In this large multicenter retrospective cohort study, AE rates of ER of T1 CRC (5.5%) are comparable with reported AE rates for adenomas. Larger tumor size and age >70 years are independent predictors for AEs. This study suggests that endoscopic treatment of T1 CRCs is not associated with an increased periprocedural AE risk.
引用
- van de Ven SEM, Backes Y, Hilbink M, et al. Periprocedural adverse events after endoscopic resection of T1 colorectal carcinomas. Gastrointest Endosc. 2019. PMID: 31525362. doi:10.1016/j.gie.2019.08.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。